Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Alzheimer's Disease

Trial Information

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients

Official Title: A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.

Summary

The objectives of the study are to evaluate the safety, tolerability and efficacy of AVP-923 compared to placebo, for the treatment of symptoms of agitation in patients with Alzheimer's Disease (AD).

Phase: Phase 2

Sponsor: Avanir Pharmaceuticals

Overall Contacts:

Paul Shin
949.268.5930

Joao Siffert, MD
Phone: 949.268.1174

Locations (29)

Country State City Zip Facility and Contact
United States Arizona Phoenix 85006 Research Site
United States Arizona Sun City 85351 Research Site
United States California Fresno 93720 Research Site
United States California Los Angeles 90095 Research Site
United States California San Diego 92103 Research Site
United States California San Francisco 94109 Research Site
United States California Sherman Oaks 91403 Research Site
United States Florida Deerfield Beach 33064 Research Site
United States Florida Miami 33137 Research Site
United States Florida Sunrise 33351 Research Site
United States Florida Tampa 33613 Research Site
United States Florida West Palm Beach 33407 Research Site
United States Florida West Palm Beach 33409 Research Site
United States Florida Weston 33331 Research Site
United States Illinois Elk Grove Village 60007 Research Site
United States Nevada Las Vegas 89106 Research Site
United States New Jersey Summit 07902 Research Site
United States New Jersey Toms River 08757 Research Site
United States New York Orangeburg 10962 Research Site
United States New York Rochester 14620 Research Site
United States Ohio Centerville 45459 Research Site
United States Ohio Cleveland 44195 Research Site
United States Ohio Columbus 43221 Research Site
United States Ohio Lakewood 44107 Research Site
United States South Carolina North Charleston 29406 Research Site
United States Texas Houston 77030 Research Site
United States Texas San Antonio 78238 Research Site
United States Utah Salt Lake City 84106 Research Site
United States Vermont Bennington 05201 Research Site

NCT ID:NCT01584440

Date Last Changed: March 1, 2013